Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.
作者信息
Pizzolo G, Chilosi M, Vinante F, Dazzi F, Lestani M, Perona G, Benedetti F, Todeschini G, Vincenzi C, Trentin L
出版信息
Br J Cancer. 1987 Apr;55(4):427-8. doi: 10.1038/bjc.1987.83.
Abstract
摘要
相似文献
1
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease.霍奇金病患者血清中的可溶性白细胞介素-2受体
Br J Cancer. 1987 Apr;55(4):427-8. doi: 10.1038/bjc.1987.83.
2
3
Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease.霍奇金病外周血和脾脏T淋巴细胞的功能评估
Br J Cancer. 1987 Dec;56(6):800-2. doi: 10.1038/bjc.1987.293.
4
5
Expression of interleukin 2 receptor on Hodgkin's and non-Hodgkin's lymphomas and macrophages.
J Clin Pathol. 1985 Oct;38(10):1196-7. doi: 10.1136/jcp.38.10.1196-b.
6
The nature of the Hodgkin cell. Report of the First International Symposium on Hodgkin's Lymphoma, Köln, Federal Republic of Germany, October 2-3, 1987.
Blut. 1988 Mar;56(3):135-7. doi: 10.1007/BF00320020.
7
Affinity of IL-2 receptors and proliferation of mitogen activated lymphocytes in Hodgkin's disease.霍奇金病中白细胞介素-2受体亲和力与丝裂原激活淋巴细胞的增殖
Br J Cancer. 1990 Mar;61(3):404-6. doi: 10.1038/bjc.1990.88.
8
Hodgkin's disease in Iraq: a clinico-pathologic study of 85 cases.伊拉克的霍奇金淋巴瘤：85例临床病理研究
Clin Oncol. 1979 Mar;5(1):69-71.
9
Serum levels of circulating ICAM-1 are increased in Hodgkin's disease.霍奇金病患者血清中循环细胞间黏附分子-1（ICAM-1）水平升高。
Leukemia. 1993 Aug;7(8):1245-9.
引用本文的文献
1
Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes.慢性肝脏疾病患者循环中可溶性白细胞介素-2 受体升高与非经典单核细胞有关。
BMC Gastroenterol. 2012 Apr 24;12:38. doi: 10.1186/1471-230X-12-38.
2
Hematopoietic growth factor receptors.造血生长因子受体。
Cytotechnology. 1989 Dec;2(4):269-86. doi: 10.1007/BF00364993.
3
Biological significance of soluble IL-2 receptor.可溶性白细胞介素 2 受体的生物学意义。
Mediators Inflamm. 1993;2(1):3-21. doi: 10.1155/S0962935193000018.
4
Mutations and regulatory anomalies effecting tumor cell immune functions.影响肿瘤细胞免疫功能的突变和调节异常。
Cancer Immunol Immunother. 2004 Jan;53(1):1-16. doi: 10.1007/s00262-003-0418-3. Epub 2003 Sep 12.
5
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.霍奇金淋巴瘤中可溶性白细胞介素-2受体（sIL-2R）：预后及临床意义
Br J Cancer. 1998 Mar;77(6):992-7. doi: 10.1038/bjc.1998.163.
6
Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies.实体恶性肿瘤患者外周血单个核细胞上的膜结合型和可溶性白细胞介素-2受体（p55和p75链）
Cell Biophys. 1993 Jan-Jun;22(1-3):79-99. doi: 10.1007/BF03033868.
7
Membrane-bound/soluble IL-2 receptor (IL-2R) and levels of IL-1 alpha, IL-2, and IL-6 in the serum and in the PBMC culture supernatants from 17 patients with hematological malignancies.17例血液系统恶性肿瘤患者血清及外周血单个核细胞培养上清液中的膜结合型/可溶性白细胞介素-2受体（IL-2R）以及白细胞介素-1α、白细胞介素-2和白细胞介素-6水平。
Cell Biophys. 1995 Aug;27(1):1-14. doi: 10.1007/BF02822523.
8
Interleukin 2 receptor in patients with localized and systemic parasitic diseases.局限性和全身性寄生虫病患者的白细胞介素2受体
Clin Exp Immunol. 1988 May;72(2):249-54.
9
Increased serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and rheumatoid arthritis.
J Clin Immunol. 1988 Nov;8(6):447-52. doi: 10.1007/BF00916949.
10
Serum soluble interleukin-2 receptor levels in patients with adult T-cell leukemia and human T-cell leukemia/lymphoma virus type-I seropositive healthy carriers.成人T细胞白血病患者及I型人类T细胞白血病/淋巴瘤病毒血清阳性健康携带者的血清可溶性白细胞介素-2受体水平
Jpn J Cancer Res. 1988 May;79(5):593-9. doi: 10.1111/j.1349-7006.1988.tb00028.x.
本文引用的文献
1
The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses.白细胞介素2在诱导细胞毒性T细胞和抗体形成B细胞反应中的生物化学、生物学及作用。
Immunol Rev. 1982;63:129-66. doi: 10.1111/j.1600-065x.1982.tb00414.x.
2
Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.毛细胞白血病中免疫球蛋白基因的重排与表达及Tac抗原的表达
Proc Natl Acad Sci U S A. 1983 Jul;80(14):4522-6. doi: 10.1073/pnas.80.14.4522.
3
Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease.霍奇金病累及组织中Tac抗原表达的免疫组织学分析。
Br J Cancer. 1984 Sep;50(3):415-7. doi: 10.1038/bjc.1984.191.
4
Inhibition of transformation of normal lymphocytes by plasma factor from patients with Hodgkin's disease and cancer.
Lancet. 1971 Dec 4;2(7736):1265. doi: 10.1016/s0140-6736(71)90586-1.
5
Natural killer cell activity during the course of disease in patients with Hodgkin's disease.霍奇金病患者病程中自然杀伤细胞活性
Cancer. 1985 Dec 15;56(12):2799-803. doi: 10.1002/1097-0142(19851215)56:12<2799::aid-cncr2820561215>3.0.co;2-w.
6
Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease.霍奇金病中霍奇金和里德-斯腾伯格细胞的表型表达。
Am J Pathol. 1985 Feb;118(2):209-17.
7
Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.可溶性白细胞介素2受体在体外从活化的人淋巴细胞中释放出来。
J Immunol. 1985 Nov;135(5):3172-7.
8
9
Lack of natural killer cell activity in hairy cell leukemia patients and partial restoration with interleukin-2.
Cancer. 1986 Mar 1;57(5):988-93. doi: 10.1002/1097-0142(19860301)57:5<988::aid-cncr2820570519>3.0.co;2-2.
10
Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia.毛细胞白血病患者血清中白细胞介素2受体可溶性形式的检测。
Int J Biol Markers. 1986 May-Aug;1(2):101-4. doi: 10.1177/172460088600100208.
Zotero 插件